STP705 for Obesity, Visceral

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Center for Clinical and Cosmetic Research, Aventura, FL
Obesity, Visceral
STP705 - Drug
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

Dose-ranging, randomized, double-blind, vehicle-controlled study

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Obesity, Visceral

Study Objectives

3 Primary · 0 Secondary · Reporting Duration: 24 weeks

24 weeks
Incidence (severity and causality) of any AEs
Number of subjects with presence and severity of the following Local Skin Reactions (LSR): erythema, edema, bruising.
Number of subjects with presence and severity of the following Local Skin Reactions (LSR): pain and stinging/burning.

Trial Safety

Safety Progress

1 of 3

Other trials for Obesity, Visceral

Trial Design

7 Treatment Groups

STP705, 120ug/mL, 0.5 cc
1 of 7
STP705, 120ug/mL, 1.0 cc
1 of 7
STP705, 240 ug/mL, 0.5 cc
1 of 7
STP705, 320ug/mL, 1.0 cc
1 of 7
STP705, 320ug/mL, 0.5 cc
1 of 7
STP705, 240ug/mL, 1.0 cc
1 of 7
Vehicle
1 of 7
Experimental Treatment
Non-Treatment Group

10 Total Participants · 7 Treatment Groups

Primary Treatment: STP705 · Has Placebo Group · Phase 1

STP705, 120ug/mL, 0.5 cc
Drug
Experimental Group · 1 Intervention: STP705 · Intervention Types: Drug
STP705, 120ug/mL, 1.0 cc
Drug
Experimental Group · 1 Intervention: STP705 · Intervention Types: Drug
STP705, 240 ug/mL, 0.5 cc
Drug
Experimental Group · 1 Intervention: STP705 · Intervention Types: Drug
STP705, 320ug/mL, 1.0 cc
Drug
Experimental Group · 1 Intervention: STP705 · Intervention Types: Drug
STP705, 320ug/mL, 0.5 cc
Drug
Experimental Group · 1 Intervention: STP705 · Intervention Types: Drug
STP705, 240ug/mL, 1.0 cc
Drug
Experimental Group · 1 Intervention: STP705 · Intervention Types: Drug
Vehicle
Drug
PlaceboComparator Group · 1 Intervention: STP705 · Intervention Types: Drug
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
STP705
2017
Completed Phase 2
~50

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 24 weeks
Closest Location: Center for Clinical and Cosmetic Research · Aventura, FL
Photo of florida 1Photo of florida 2Photo of florida 3
2013First Recorded Clinical Trial
0 TrialsResearching Obesity, Visceral
15 CompletedClinical Trials

Who is running the clinical trial?

SirnaomicsLead Sponsor
10 Previous Clinical Trials
445 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are post-menopausal, surgically sterile, or use an effective method of birth control.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.